These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9847972)
21. Role of surgery in the treatment of motor complications. Metman LV; O'Leary ST Mov Disord; 2005; 20 Suppl 11():S45-56. PubMed ID: 15822076 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in the clinical pharmacology of Parkinson's disease. Montastruc JL Therapie; 1991; 46(4):293-303. PubMed ID: 1683024 [TBL] [Abstract][Full Text] [Related]
23. [Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson's disease]. Nomoto M; Nakatsuka A; Nagai M; Yabe H; Moritoyo T; Moritoyo H; Nisikawa N Rinsho Shinkeigaku; 2005 Nov; 45(11):895-8. PubMed ID: 16447756 [TBL] [Abstract][Full Text] [Related]
24. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Chen JJ; Swope DM; Dashtipour K Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186 [TBL] [Abstract][Full Text] [Related]
26. Recognition and treatment of response fluctuations in Parkinson's disease: review article. Verhagen Metman L Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528 [TBL] [Abstract][Full Text] [Related]
28. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias. Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640 [TBL] [Abstract][Full Text] [Related]
29. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079 [TBL] [Abstract][Full Text] [Related]
30. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
31. Treatment of motor dysfunction in Parkinson's disease: an overview. Thobois S; Delamarre-Damier F; Derkinderen P Clin Neurol Neurosurg; 2005 Jun; 107(4):269-81. PubMed ID: 15885384 [TBL] [Abstract][Full Text] [Related]
32. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients]. Hironishi M; Miwa H; Kondo T No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758 [TBL] [Abstract][Full Text] [Related]
33. DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism. Shoulson I Ann Neurol; 1998 Sep; 44(3 Suppl 1):S160-6. PubMed ID: 9749589 [TBL] [Abstract][Full Text] [Related]
34. Management of parkinson's disease--combined therapy with levodopa and thalamotomy. Mosso JA; Rand RW West J Med; 1975 Jan; 122(1):1-6. PubMed ID: 1109524 [TBL] [Abstract][Full Text] [Related]
35. Rationale for current therapies in Parkinson's disease. Romrell J; Fernandez HH; Okun MS Expert Opin Pharmacother; 2003 Oct; 4(10):1747-61. PubMed ID: 14521485 [TBL] [Abstract][Full Text] [Related]
40. Current approaches in the treatment of Parkinson's disease. Stacy M; Jankovic J Annu Rev Med; 1993; 44():431-40. PubMed ID: 8476262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]